GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Meheco Group Co Ltd (SHSE:600056) » Definitions » Forward PE Ratio

China Meheco Group Co (SHSE:600056) Forward PE Ratio : 0.00 (As of May. 28, 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Meheco Group Co Forward PE Ratio?

China Meheco Group Co's Forward PE Ratio for today is 0.00.

China Meheco Group Co's PE Ratio without NRI for today is 23.07.

China Meheco Group Co's PE Ratio for today is 17.51.


China Meheco Group Co Forward PE Ratio Historical Data

The historical data trend for China Meheco Group Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Meheco Group Co Forward PE Ratio Chart

China Meheco Group Co Annual Data
Trend
Forward PE Ratio

China Meheco Group Co Quarterly Data
Forward PE Ratio

Competitive Comparison of China Meheco Group Co's Forward PE Ratio

For the Medical Distribution subindustry, China Meheco Group Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Meheco Group Co's Forward PE Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China Meheco Group Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where China Meheco Group Co's Forward PE Ratio falls into.



China Meheco Group Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


China Meheco Group Co  (SHSE:600056) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


China Meheco Group Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of China Meheco Group Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Meheco Group Co (SHSE:600056) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Guangming Zhongjie, Dongcheng District, Beijing, CHN, 100061
China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products and others.
Executives
Qi Jian Xi senior management
Ni Xiao Ling Director

China Meheco Group Co (SHSE:600056) Headlines

No Headlines